KRM 1668

Known as: KRM-1668, Rifamycin VIII, 1',4-didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-5'-(4-(1-methylpropyl)-1-piperazinyl)-1-oxo- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-1997
01219911997

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Comparative activities of various rifamycin analogues against leprosy were studied by evaluating their effects on in vitro growth… (More)
Is this relevant?
1995
1995
The activities of four newly synthesized benzoxazinorifamycin derivatives, either alone or in combination with ofloxacin, against… (More)
Is this relevant?
1991
1991
Newly synthesized rifamycin derivatives, KRM-1648, KRM-1657, KRM-1668, KRM-1686, and KRM-1687, having the chemical structures of… (More)
  • figure 1
  • figure 2
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
1991
Review
1991
  • F. Kuze
  • Kekkaku : [Tuberculosis]
  • 1991
The Standard Initial Chemotherapy, chemotherapeutic activity of which depends mostly on the two potent bactericidal drugs, INH… (More)
Is this relevant?